BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3291774)

  • 1. [Potential use of positron-emission tomography in clinical oncology].
    Fukuda H; Matsuzawa T; Tateno Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer diagnosis with positron emission tomography (PET)].
    Kubota K
    Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography in oncology: the most sophisticated imaging technology.
    Lacić M; Maisey MN; Kusić Z
    Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in oncology.
    Leskinen-Kallio S
    Clin Physiol; 1994 May; 14(3):329-35. PubMed ID: 8026150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of early cancer with positron emission tomography].
    Kubota K
    Nihon Rinsho; 1996 May; 54(5):1263-7. PubMed ID: 8965348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 9. PET and [18F]-FDG in oncology: a clinical update.
    Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
    Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 11. The applications of PET in clinical oncology.
    Strauss LG; Conti PS
    J Nucl Med; 1991 Apr; 32(4):623-48; discussion 649-50. PubMed ID: 2013803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positron emitters for the study of tumor metabolism].
    Strauss LG
    Radiologe; 1989 Jul; 29(7):318-21. PubMed ID: 2667030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid increase of the use of PET in cancer investigation--but Sweden lags behind].
    Wollmer P; Valind S; Landoni C; Fazio F
    Ugeskr Laeger; 2000 Jul; 162(27):3846-8. PubMed ID: 10920697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heritage of radiotracers for positron emission tomography.
    Fowler JS; Wolf AP
    Acta Radiol Suppl; 1990; 374():13-6. PubMed ID: 1966960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Positron emission tomography (PET) in oncology (Part I)].
    Gámez Cenzano C; Cabrera Villegas A; Sopena Monforte R; García Velloso MJ
    Rev Esp Med Nucl; 2002 Feb; 21(1):41-60; quiz 61-3. PubMed ID: 11821003
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
    Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
    J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
    Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
    Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.